NASDAQ:OTLK

Outlook Therapeutics Stock Predictions

etoro logo Buy OTLK
*Your capital is at risk
$0.81
-0.0038 (-0.467%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

OTLK Prediction Chart

OTLK Predictions History

Latest community submissions for OTLK.
Predictor Target Session Target Price Result Direction Accuracy Score
Aug 1, 2025 Bullish $1.93 X 0
Jul 31, 2025 $1.99 -2.77% $1.96 V 98.30% 1
Jul 31, 2025 $2.01 -1.73% $1.96 V 97.22% 1
Jul 31, 2025 $1.99 +1.02% $1.96 X 98.47% 0
Jul 29, 2025 $2.05 +1.79% $1.97 X 96.14% 0
Jul 29, 2025 $2.15 +6.97% $1.97 X 90.86% 0
Jul 25, 2025 $2.06 +3.02% $2.04 V 99.00% 2
Jul 25, 2025 $2.04 +1.89% $2.04 V 99.89% 6
Jul 25, 2025 $2.30 +10.58% $2.04 X 87.25% 1
Jul 23, 2025 $2.14 +3.08% $2.08 X 96.92% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for OTLK with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT OUTLOOK THERAPEUTICS INC.
Outlook Therapeutics
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and lice...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE